AN IMPROVED METHOD FOR THE SYNTHESIS OF HIGH-PURITY 2-NITROMESITYLENE AS AN IMPORTANT INTERMEDIATE FOR THE PREPARATION OF THE HIV MEDICATION RILPIVIRINE
Main Article Content
Abstract
Background: Rilpivirine, an HIV treatment drug approved for use in the United States since May 2011 under the trade name Edurant, needs to be studied for synthesis using inexpensive and locally available materials to reduce dependence on imports. 2-Nitromesitylene, a key intermediate in many rilpivirine synthesis processes, currently faces challenges in synthesis and purification due to the selectivity of the reaction. Additionally, quality control of the product is a mandatory requirement in the registration of active pharmaceutical ingredients (API) in Vietnam. Objectives: The synthesis and purification of 2-nitromesitylene with high purity can be achieved through the nitration of mesitylene using a new nitrating agent. Materials and Methods: The synthesis of 2-nitromesitylene was carried out by nitration of mesitylene using acylnitrate (acetyl nitrate) as the reagent, with an investigation into factors affecting the reaction selectivity. The product structure was characterized using IR, MS, ¹H-NMR, and ¹³C-NMR spectroscopy, while its purity was evaluated through thin-layer chromatography (TLC), melting point determination, and high-performance liquid chromatography (HPLC). Results: Nitration of mesitylene using a novel reagent, acetyl nitrate (comprising 65% nitric acid in acetic anhydride), at a scale of 2 g per batch achieved a yield of 95.6%. The structure of the product was accurately confirmed by melting point determination, IR, MS, ¹H-NMR, and ¹³C-NMR spectra. Optimization of the molar ratio of acetyl nitrate to mesitylene (1.4:1.0) and reaction temperature (5–15 °C) enabled upscaling of the synthesis and purification to 30 g per batch, with a stable yield of 93.9%. New conditions for the HPLC method were established, confirming the product's purity at 99.37%. Conclusion: 2-Nitromesitylene with a purity of 99.37% (HPLC) was successfully synthesized and purified through the nitration of mesitylene using a novel reagent, 65% nitric acid, at a scale of 30 g per batch, achieving a yield of 93.9%.
Article Details
Keywords
mesitylene, acetylnitrate, 2-nitromesitylene, rilpivirine, HPLC
References
2. Sharma M.,Saravolatz L. D. Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor. J Antimicrob Chemother. 2013.68(2), 250-6, https://doi.org/10.1093/jac/dks404.
3. FDA (2011). EDURANT (rilpivirine, RPV) oral tablets.
4. Popović-Djordjević J., Quispe C., Giordo R., et al. Natural products and synthetic analogues against HIV: A perspective to develop new potential anti-HIV drugs. Eur J Med Chem. 2022. 233, 114217, https://doi.org/10.1016/j.ejmech.2022.114217.
5. Nguyễn Văn Giang, Nguyễn Đình Luyện, Nguyễn Văn Hải, Mai Văn Tiến, Đào Nguyệt Sương Huyền. Phương pháp điều chế rilpivirin từ mesitylen dùng làm thuốc điều trị HIV. Giải pháp hữu ích số VN 2-0003611. 2021.
6. Liu Shengpeng, Xie Zhihan, Wu Xiaoyu, Xu Lili, Xiong Yun, Sun Guofeng, Ding Yigang,. Synthesis method of rilpivirine intermediate, CN Patent CN111333543A. 2020.
7. Zhang Q., Wu Y.,. 2,4,6-trimethylaniline synthesis method, CN Patent CN1800143A.2006.
8. Allen W. Graff M. Mononitration of 1, 3, 5-trialkylbenzene, US Patent US3078317A. 1963.
9. Didier P. at all. Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]2-pyrimidinyl]amino]benzonitrile, WO Patent WO2004016581A1. 2004.
10. Bộ Y tế. Thông tư Số 35/2018/TT-BYT ngày 22 tháng 11 năm 2018 Quy định về thực hành tốt sản xuất thuốc, nguyên liệu làm thuốc.
11. Powell G., Johnson F. R., Nitromesitylene. Org. Synth. 1934.14, 68, https://doi.org/10.15227/orgsyn.014.0068.
12. EMEA. ICH Q7 Good manufacturing practice for active pharmaceutical ingredients - Scientific guideline. 2016
13. Teasdale A., Elder, D., & Nims, R. W. (Eds.). ICH quality guidelines: An implementation guide. John Wiley & Sons. 2017.
14. Nguyễn Văn Giang, Bùi Thị Phương Mai, Đặng Ngọc Dương, Nguyễn Văn Hải. Nghiên cứu cải tiến quá trình mononitro hóa mesitylen. Hóa học và Ứng dụng. 2022.1B(60B), (333).